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Previous studies have demonstrated that TGFh induces a smooth muscle fate in primary neural crest cells in culture. By crossing a conditional
allele of the type II TGFh receptor with the neural crest-specific Wnt1cre transgene, we have addressed the in vivo requirement for TGFh
signaling in smooth muscle specification and differentiation. We find that elimination of the TGFh receptor does not alter neural crest cell
specification to a smooth muscle fate in the cranial or cardiac domains, and that a smooth muscle fate is not realized by trunk neural crest cells in
either control or mutant embryos. Instead, mutant embryos exhibit with complete penetrance two very specific and mechanistically distinct
cardiovascular malformations—persistent truncus arteriosus (PTA) and interrupted aortic arch (IAA-B). Pharyngeal organ defects such as those
seen in models of DiGeorge syndrome were not observed, arguing against an early perturbation of the cardiac neural crest cell lineage. We infer
that TGFh is an essential morphogenic signal for the neural crest cell lineage in specific aspects of cardiovascular development, although one that
is not required for smooth muscle differentiation.
D 2005 Elsevier Inc. All rights reserved.Keywords: Neural crest; TGFh; Type II receptor; Persistent truncus arteriosus; Interrupted aortic arch; DiGeorge syndromeIntroduction
Multipotent progenitor cells generally receive instructional
cues that direct their differentiation and choice of fate. The
neural crest cell lineage is one such progenitor population.
Neural crest cells arise at all axial levels of the dorsal neural
tube just prior to neural tube closure, and then migrate to
peripheral locations. Fate mapping studies in avian embryos
(LeDouarin, 1982) and more recently in mouse embryos (Jiang
et al., 2000; Chai et al., 2000) have demonstrated that a variety
of ectodermal and mesodermal fates are assumed by this cell
lineage in normal development. Transplantation studies have
demonstrated that neural crest cells isolated from the neural
tube retain considerable plasticity when reintroduced into new
locations (LeDouarin, 1982), leading to the inference that0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.11.008
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E-mail address: sucov@usc.edu (H.M. Sucov).signals in the local environments into which the neural crest
cells migrate direct the differentiation of these cells.
Among the many factors which are believed to instruct
pleuripotent neural crest cells to differentiate to specific fates,
TGFh has for several years been suggested to promote smooth
muscle differentiation. Thus, primary embryonic neural crest
cells cultured in vitro will differentiate to smooth muscle with
very high frequency when exposed to TGFh, but not to a
variety of other factors (Shah et al., 1996). Recent studies have
suggested that TGFh has differing effects on neural crest cells
that arise at different axial levels: trunk neural crest cells
assume a smooth muscle fate when exposed to TGFh, whereas
this fate is suppressed by TGFh in cranial neural crest cells
(Abzhanov et al., 2003). Because these studies have been
undertaken with cells cultured in vitro, the in vivo relevance of
these approaches has been uncertain.
As conventionally understood (Massague, 2000), TGFh
signals are received through cell surface receptors that
obligatorily include the type II TGFh receptor. This receptor89 (2006) 420 – 429
www.e
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receptors that mediate other ligand signals are well known. In
the presence of ligand, the type II receptor phosphorylates a
type I receptor to initiate intracellular signal transduction.
ALK5 is the conventional type I receptor for TGFh signaling,
although ALK1 has been suggested as an additional type I
TGFh receptor in endothelial cells, and ALK2 may be involved
in mediating TGFh signals in the endocardial cushions of the
heart. In many cases, TGFh signals are transduced via
activation of Smad proteins, although several Smad-indepen-
dent alternative pathways may also be important in certain
processes (Derynck and Zhang, 2003).
Conventional knockout of the Tgfbr2 gene in mice results in
yolk sac hematopoietic and vasculogenic defects, causing
visibly disrupted embryonic development by E9.5 and lethality
by E10.5 (Oshima et al., 1996). A similar phenotype is
obtained in mice lacking the type I receptor (ALK5) (Larsson
et al., 2001). To circumvent this early phenotype, and to
address the role of TGFh and its receptors in neural crest
biology, we crossed a conditional Tgfbr2 allele (Chytil et al.,
2002) with the Wnt1cre transgene (Danielian et al., 1998). This
transgene directs highly efficient recombination of target genes
specifically in the neural crest cell lineage at all axial levels of
the embryo (Jiang et al., 2000; Chai et al., 2000). Homozygous
Wnt1cre/Tgfbr2 embryos are delivered at full term at normal
size, although with severe cranial (Ito et al., 2003) and
cardiovascular (see below) malformations, and die in the
immediate postnatal period. We find that TGFh signal
reception by neural crest is essential for two very specific
morphogenic processes in cardiovascular development –
formation of the aorticopulmonary septum and preservation
of the arch of the aorta – but is dispensable for smooth muscle
specification and differentiation.Materials and methods
TheWnt1cre (Danielian et al., 1998), R26R (Soriano, 1999) and conditional
Tgfbr2 (Chytil et al., 2002) alleles have been previously described. Xgal staining
of embryos in whole mount and of frozen sections was as previously describedFig. 1. Cranial neural crest contribution to smooth muscle. (A–B) Evaluation o
hybridization using a probe specific for exon 2 of the Tgrfbr2 gene shows expression
in control E12.5 embryos (A), whereas in Wnt1cre/Tgrfbr2 mutants (B), mesench
adjacent sections through control (C, E) or Wnt1cre/Tgfbr2 (D, F) E13.5 embryos
basilar (b) and middle cerebral (c) arteries. Regardless of Tgfbr2 status, the smooth m
the smooth muscle layer of the basilar artery is mesodermal in origin (Xgal-negativ(Jiang et al., 2000). Primary antibodies used were against smooth muscle a actin
(monoclonal 1A4, Sigma), phospho-histone H3 (Upstate), and active caspase 3
(Promega), with HRP-conjugated secondary antibody and DAB/H2O2 detection.
Rabbit polyclonal antibody against mouse tropoelastin (6–17) was kindly
provided by Robert Mecham. For BrdU detection, pregnant females were
injected with 100 Ag BrdU/g body weight 2 h before sacrifice, followed by
fixation and paraffin embedding, with immunodetection using reagents from
Zymed. For in situ hybridization detection of parathyroid hormone, a
digoxygenin-labeled antisense probe (corresponding to 97–534 of NM_
020623.1) was generated by transcription in vitro from a template kindly
provided by Nancy Manley, and following hybridization to paraffin sectioned
tissue was detected with anti-digoxygenin alkaline phosphatase-coupled
antibody (Roche) and BCIP/NBT substrate kit (Zymed). For detection of Tgfbr2
transcript, a 35S-UTP-labeled antisense probe representing exon 2 (422–590 of
NM_009371.2) was hybridized to paraffin sections and visualized by exposure to
photographic emulsion. Whole mount in situ hybridization utilized probes for
CRABPI (285–435 of NM_013496) and AP2a (559–1559 of NM_011547).
India ink visualization of embryonic vasculature was achieved by intracardiac
injection, followed by fixation and clearing with methyl salicylate.
Results
Neural crest contribution to cranial smooth muscle
Neural crest constitutes the vast majority of cranial
mesenchyme (Jiang et al., 2000; Chai et al., 2000), although
paraxial mesoderm also contributes mesenchyme in the head.
To assess the efficiency of recombination of the conditional
Tgfbr2 allele by the Wnt1cre transgene, we undertook in situ
hybridization studies using a probe specific for exon 2 of the
Tgfbr2 gene, the exon that is deleted after cre-mediated
recombination. The Tgfbr2 gene is expressed in midgestation
embryos in the first pharyngeal arch ectoderm and mesen-
chyme; when crossed to the Wnt1cre allele, signal is still
readily detectable in ectoderm, but is reduced to background in
neural crest-derived mesenchyme (Figs. 1A–B).
As vasculogenesis is initiated in development, endothelial
cells of nascent vessels recruit mesenchymal cells in their
vicinity to a smooth muscle fate, as exemplified by immunore-
activity against smooth muscle a actin (SMA). The neural crest
origin of smooth muscle was assessed in control (Wnt1cre
transgenic) and mutant (Wnt1cre/Tgfbr2) embryos via thef Wnt1cre-mediated recombination of the conditional Tgfbr2 allele. In situ
in first arch mesenchyme (m; primarily neural crest-derived) and ectoderm (ect)
ymal expression is abolished but ectodermal expression persists. (C–F) Near
stained for Xgal (C–D) or anti-smooth muscle actin (E–F), emphasizing the
uscle layer of the cerebral artery is neural crest-derived (Xgal-positive), whereas
e).
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staining of adjacent sections with anti-SMA antibody or with
Xgal. Sections through the head of midgestation embryos
indicated that some cranial blood vessels were completely
surrounded by Xgal-positive smooth muscle cells (e.g., middle
cerebral arteries (Figs. 1C–F) and maxillary and stapedial
arteries (not shown)), where others had a smooth muscle
investment that was not neural crest-derived (e.g., the basilar
artery (Figs. 1C–F) and vertebral arteries (not shown)). The
distribution and lineage origin of cranial smooth muscle was not
altered inWnt1cre/Tgfbr2 mutant embryos (Figs. 1D, F and data
not shown). We have previously described major cranial
malformations associated with the Wnt1cre/Tgfbr2 background
(Ito et al., 2003), although we did not observe any obvious
differences in vascular patterning associated with neural crest-
specific absence of Tgfbr2.
Neural crest does not contribute to abdominal smooth muscle
In our previous studies (Jiang et al., 2000; Chai et al., 2000),
we employed the Wnt1cre and R26R alleles to fate map the
neural crest cell lineage in the head and heart (thorax), although
trunk neural crest populations had not specifically been
examined. We therefore examined sections through mid- and
late-gestation embryos that carried the Wnt1cre/R26R reporter
combination, and were either homozygous for the conditional
Tgfbr2 allele or were normal controls. We did not observe
abdominal morphogenic defects in anyWnt1cre/Tgfbr2 mutants
(data not shown), although these embryos have cranial and
cardiac defects with complete penetrance. More importantly, we
also noted that the normal fate of the trunk neural crest lineage
does not include a contribution to smooth muscle, irrespective of
the presence of a functional Tgfbr2 gene. Neural crest-derived
(Xgal-positive) cells were readily observed in the abdominal
region, but were not SMA-immunoreactive, and all smooth
muscle was Xgal-negative, including both vascular as well as
visceral smooth muscle (Fig. 2). The primary Xgal-positive cellFig. 2. Absence of neural crest contribution to trunk smooth muscle. Sections shown
at E14.5, emphasizing: (A) the dorsal (abdominal) aorta (arrow) and the developing
and counterstained with nuclear fast red (left panel of each pair), or immunostained
muscle layer of all abdominal blood vessels, including the dorsal aorta and its bran
shown) are not Xgal stained. In the intestine and other viscera, SMA-positive smooth
not costain (B). Neural crest cells in the adrenal (* in A) will ultimately become thtypes in the abdominal region were neurons associated with
visceral innervation, although additional cell types, such as
chromaffin cells of the adrenal medulla, were also labeled. In all
cases, we did not observe any difference in the pattern of cell
distribution or fate between neural crest-derived cells that were
sufficient or lacking in the type II TGFh receptor.
Cardiovascular defects in Wnt1cre/Tgfbr2 mutants
In normal mouse development, the early (up to E10.5) heart
outflow tract is a single vessel that branches at a structure
known as the aortic sac into the bilaterally symmetric 3rd, 4th,
and 6th pharyngeal arch arteries. A substantial population of
neural crest-derived cells in the pharyngeal arches remains
associated with the pharyngeal arch arteries, and constitutes the
smooth muscle layer that surrounds these vessels as they
become reorganized into the arch of the aorta, the ductus
arteriosus, and the proximal segments of the carotid arteries
(Kirby and Waldo, 1995; Jiang et al., 2000). Neural crest cells
that migrate to the aortic sac are required to divide this structure
into distinct aortic and pulmonary components, via the
formation of a transient structure known as the aorticopulmon-
ary (A/P) septum; the A/P septum then resolves into smooth
muscle that lies immediately adjacent to the vascular endothe-
lium of the ascending aorta and the pulmonary trunk (the outer
layer of smooth muscle of these vessels is derived from
splanchnic mesoderm). Neural crest cells also migrate deeper
into the conotruncal cushions and are instrumental in directing
morphogenic events that result in the proper alignment of the
ascending aorta and of the pulmonary trunk with the left and
right ventricles. Reorganization of the cardiac outflow tract and
associated vessels is underway at E11.5 in the mouse, and is
completed by E12.5.
Histological examination determined that allWnt1cre/Tgfbr2
mutant embryos at E12.5 or older had the outflow tract
malformation persistent truncus arteriosus (PTA), specifically
the subtype known as PTA-A4 (see below). This included 21 ofare from control embryos (upper row) andWnt1cre/Tgfbr2 embryos (lower row)
adrenal (*); and (B) the intestine. Near adjacent sections were stained with Xgal
with anti-smooth muscle actin antibody (right panel of each pair). The smooth
ches (A) and other blood vessels associated with the gut and other viscera (not
muscle and Xgal-positive presumptive neurons lie adjacent to each other but do
e adrenal medulla.
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anatomy, as well as all additional embryos which were examined
in other assays described below. The mutant embryos included
those that were simply Wnt1cre/Tgfbr2, as well as embryos that
were Wnt1cre/R26R/Tgfbr2, the latter demonstrating that
inclusion of the R26R lineage marker does not alter recombi-
nation efficiency or otherwise alter the phenotype of Tgfbr2
deficiency. PTA results from a failure in the formation of the A/P
septum,which in normal embryos is comprised entirely of neural
crest cells that populate the aortic sac (Jiang et al., 2000). PTA
was recognizable in these embryos by the presence of a single
outflow vessel (the truncus arteriosus) exiting the heart, instead
of the normally distinct ascending aorta and pulmonary trunk
(Fig. 3). Distal to the valve apparatus, the truncus arteriosus
bifurcated into distinct vessels representing the ascending aorta
and the ductus arteriosus (i.e., the left 4th and 6th arch arteries,
respectively). In all mutant embryos, outflow valve leaflets were
formed, in what appeared to be a fairly normal individual
morphology (Fig. 3). All mutant embryos had a ventricular
septal defect (data not shown), which is an obligate hemody-
namic necessity of PTA.
In everyWnt1cre/Tgfbr2 embryo at E12.5 or older, PTAwas
accompanied by an interruption of the aortic arch between the
left carotid artery and the left subclavian artery (IAA type B;Fig. 3. Cardiovascular malformations inWnt1cre/Tgfbr2 mutants. (A–B)Whole
mount views of the vascular anatomy of control (A) andWnt1cre/Tgfbr2 mutant
(B) embryos at E18. The arrowhead in A points to the arch of the aorta, and in B
points to where this structure is missing. (C–D) Histological sections through
control (C) and mutant (D) E14.5 embryos. Note in D the single outflow vessel
(TA) which branches distal to the outflow valve leaflets into the ascending aorta
and ductus arteriosus. Note also in D the retroesophageal position of the rsca in
this embryo. Abbreviations: Ao, ascending aorta; dAo, dorsal aorta; E,
esophagus; DA, ductus arteriosus; PT, pulmonary trunk; T, trachea; TA, truncus
arteriosus; rca, rsca, lca, lsca, right and left carotid and subclavian arteries; rersca,
retroesophageal rsca.Fig. 3B). This combination of malformations is defined
clinically (van Praagh and van Praagh, 1965) as PTA type
A4. In such embryos, the ascending aorta branches into the
carotid arteries but does not connect to the dorsal (descending)
aorta, and the dorsal aorta is supplied solely via the ductus
arteriosus. In 12/17 cases, the right subclavian artery originated
from the ascending aorta via a normal innominate artery;
however, in 5/17 cases, the right subclavian artery originated
retroesophageally from the dorsal aorta (e.g., Fig. 3D).
Developmentally, IAA-B is caused by inappropriate regression
of the left 4th aortic arch artery, whereas a retroesophageal
right subclavian artery is caused by inappropriate regression of
the right 4th arch artery (and consequently, by the obligate
preservation of the right dorsal aorta). Thus, all Wnt1cre/
Tgfbr2 mutants suffer from a failure in the left 4th arch artery,
and approx. 30% also suffer from a failure of the right 4th arch
artery. The cardiovascular phenotype of PTA with interrupted
aortic arch is compatible with fetal viability, and along with the
craniofacial defects of these embryos (Ito et al., 2003) is
sufficient to explain the lethality of Wnt1cre/Tgfbr2 mutants in
the immediate postnatal period.
Normal cardiovascular morphology and neural crest cell
distribution in early Wnt1cre/Tgfbr2 mutant embryos
We examined Wnt1cre/Tgfbr2 mutant embryos at E10.5 and
through later development to address the basis of the
cardiovascular phenotypes seen in these mutants. Whole-mount
Xgal stained Wnt1cre/R26R/Tgfbr2 embryos at E10.5, E11.0,
and E11.5 are shown in Figs. 4A–C. Collectively, these images
demonstrate that the gross cell number and migration pattern of
the neural crest cell lineage were normal in mutant embryos.
One can also appreciate, particularly in the E10.5 embryos, that
the overall morphology of the caudal pharyngeal region was
normal in mutant embryos, including the clear demarcation of
the 3rd and 4th pharyngeal pouches and the normal size of the
3rd, 4th, and 6th pharyngeal arches. Furthermore, the paired
streams of cells that migrate into the conotruncal cushions were
present in apparently normal numbers in normal and mutant
embryos throughout this period, and in an apparently normal
distribution. Whole mount in situ hybridization of E10.0
embryos using probes for CRABPI and AP2a confirmed the
normal phenotype of the migrating neural crest cell population
(data not shown).
India ink visualization of the outflow tract vasculature at
E10.5 (Figs. 4D, J) revealed no obvious alteration in the
normal pattern of the 3rd, 4th, and 6th pharyngeal arch
arteries in mutant embryos. Sections through E10.5 Xgal-
stained embryos (Figs. 4E–I, K–O) demonstrated a com-
pletely normal pattern of the aortic arch arteries themselves,
and of the neural crest cell distribution around these vessels
and in the outflow tract. In both normal and mutant embryos
at E10.5, the 4th and 6th arch arteries were surrounded by
neural crest-derived mesenchymal cells, although these cells
had not yet coalesced and differentiated into smooth muscle
(as defined by expression of smooth muscle actin; data not
shown). In the outflow tract, Xgal-positive (neural crest)
Fig. 4. Initial vascular development is normal in Wnt1cre/Tgfbr2 mutant embryos. (A–C) Whole mount views of Xgal-stained littermate embryos isolated at the
indicated developmental times; in each panel, a normal embryo is to the left, and a mutant to the right. The large arrows point to the stream of labeled neural crest-
derived cells in the conotruncus, and in E10.5 embryos the smaller arrow points to the 3rd pouch. (D, J) India ink visualization of the aortic arch arteries (numbered)
in E10.5 control (D) and mutant (J) embryos. (E– I, K–O) Location of neural crest cells in E10.5 control (E– I) and mutant (K–O) embryos. Sections are shown at
the level of the 4th arch artery (E, K), the aortic sac (F–G, L–M), and the conotruncus (G–I, M–O). Arrows in G, H, M, N indicate the normal spiral orientation of
the conotruncal cushions, which have a high percentage of neural crest-derived cells. P–GG, location of neural crest-derived cells and smooth muscle actin
expression at E11.5. Approximately corresponding sections from normal embryos (P–U, BB–DD) and Tgfbr2 mutant embryos (V–AA, EE–GG) are shown. Xgal-
stained sections in P–R and V–X are adjacent to SMA-stained sections in S–U and Y–AA, respectively; sections in BB–DD and EE–GG are from a different pair
of E11.5 embryos. Panels shown are at the level of the 4th arch artery (P, S, BB, V, Y, EE), the aortic sac (Q, T, CC, W, Z, FF), and the level of the 6th arch artery (R,
U, DD, X, AA, GG). Arrows in Q, T, CC, W, Z, and FF indicate the location of SMA-positive and Xgal-positive neural crest cells at the site where the A/P septum
normally forms. Abbreviations: AoS, aortic sac; CT, conotruncus; others as in Fig. 3 legend; numbers indicate aortic arch arteries.
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surrounding the aortic sac and streaming into the conotruncal
cushions. A substantial percentage of the mesenchyme of the
conotruncal cushions was neural crest-derived, in both
normal and mutant embryos, and the spiral organization of
the conotruncal cushions was normal in mutant embryos as
well.In normal development, the initial bilateral organization
of the outflow tract and arch arteries is established at
E10.5, and does not begin reorganization until E11.0. We
therefore conclude that transduction of TGFh signals by the
type II TGFh receptor in the cardiac neural crest cell
lineage has no required role in the specification and
migration of this cell population, nor in the initial formation
Fig. 5. Normal proliferation inWnt1cre/Tgfbr2 mutant embryos. Normal (A, C)
or Tgfbr2-deficient (B, D) embryos at E11.0 (A, B; prior to formation of the A/
P septum) and E11.5 (C, D; following A/P septation in normal embryos) were
sectioned through the aortic sac, and immunostained for BrdU; proliferating
cells stain dark brown. A comparable percentage of labeled presumptive neural
crest-derived mesenchymal cells are between the distal end of the aortic sac
(AoS) and the foregut (FG) at E11.0, and at E11.5 are in the completed A/P
septum between the ascending Ao and pulmonary trunk of control embryos (C)
and surrounding the non-septated truncus arteriosus of mutant embryos (D).
B. Choudhary et al. / Developmental Biology 289 (2006) 420–429 425and organization of the outflow tract and of the aortic arch
arteries.
Normal smooth muscle specification in the pharyngeal arches
of mutant embryos
In contrast to cranial neural crest, where smoothmuscle is one
of many fates that is assumed, and in contrast to trunk neural
crest, which do not become smooth muscle, the fate of a
substantial portion of the cardiac neural crest cell lineage is to
become smooth muscle (Jiang et al., 2000). Smooth muscle
specification of neural crest-derived cells in the caudal pharyn-
geal arches was first evident at E11.0 (data not shown) by
immunostaining for the presence of smooth muscle actin, and
was quite obvious by E11.5 (Figs. 4P–GG). The smooth muscle
layer of the 4th and 6th arch arteries was derived from the neural
crest cell lineage equivalently in normal and mutant embryos
(see also below). We conclude that the type II TGFh receptor is
not required in the cardiac neural crest cell lineage for normal
smooth muscle specification, and infer that TGFh signaling is
also not required by these cells for specification of a smooth
muscle fate.
Absence of formation of the aorticopulmonary septum in
mutant embryos
The aorticopulmonary (A/P) septum is a wedge of neural
crest-derived tissue that partitions the aortic sac into distinct
aortic and pulmonary channels connected to the 4th and 6th
arch arteries, respectively. At E11.5, and depending on the
exact age of the litter, the A/P septum is not yet fully
formed, but its presence is certainly apparent. In Wnt1cre/
R26R (normal) embryos at E11.5, a wedge of Xgal-positive
cells was apparent at the distal end of the aortic sac (Fig.
4Q), and these cells were immunopositive for smooth muscle
actin as well (Figs. 4T, CC). However, in Wnt1cre/Tgfbr2
mutant embryos, this wedge of tissue failed to form. An
aggregation of Xgal-positive cells was seen in the appropri-
ate position and in what appeared to be a normal number
(Fig. 4W), and these cells were also smooth muscle actin-
positive (Figs. 4Z, FF), but the formation of the A/P septum
by these cells failed to occur. The truncus arteriosus therefore
remained the common source from which the 4th and 6th
arch arteries originated.
One possible cellular mechanism by which the A/P septum
might not form could be through a proliferative failure by the
neural crest cell lineage, thereby never accumulating a
sufficient number of cells to form the wedge of tissue that
comprises the A/P septum. As argued above, the global cell
number and distribution of the cardiac neural crest cell lineage
seems normal in mutant embryos, although a very local
proliferative failure had not been specifically examined. We
therefore examined litters at E11.0 (prior to the appearance of
the A/P septum; Figs. 5A–B) and at E11.5 (once A/P septal
formation is evident in control embryos; Figs. 5C–D) for signs
of a proliferative defect associated with absence of the TGFh
type II receptor. We detected proliferative cells by BrdUincorporation; in E11.0 embryos in the region between the
aortic sac and the foregut at an axial level between the 4th and
6th aortic arch arteries (i.e., the location at which the A/P
septum forms), the same proliferative index was measured in
control (50.4 T 1.2%) and mutant (51.7 T 1.0%) embryos (n = 4
embryos of each genotype). A parallel analysis using immu-
noreactivity against phosphorylated histone H3 as a marker of
proliferation also did not reveal any difference between normal
and mutant embryos (data not shown). An investigation of
apoptosis (immunostaining for activated caspase 3 or for
TUNEL immunoreactivity) did not reveal any apoptotic cells
in the vicinity of the aortic sac at E11.0–11.5 in normal nor
mutant embryos (data not shown).
The impending failure in the formation of the A/P septum
seen in mutant embryos at E11.0–11.5 (described above) is
complete by E12.5. Thus, at this stage (Figs. 6A–B) and all
later stages (e.g., Fig. 3), a single outflow vessel (the truncus
arteriosus) was seen to exit the heart and then bifurcate into
the ascending aorta and the ductus arteriosus.
Apoptosis associated with regression of the left 4th arch artery
At E11.5, the 4th arch arteries were normally organized in
Tgfbr2-deficient embryos, and were enveloped by a normally
appearing layer of smooth muscle (described above). How-
ever, in mutant embryos at E12.5, the left 4th arch artery had
completely regressed. Immunostaining at the level of the arch
of the aorta in control embryos revealed the presence of
smooth muscle actin-positive (neural crest-derived) cells that
had already been incorporated into the wall of the 4th arch
artery (Fig. 6C). There was effectively no apoptosis in the
vicinity of the normal 4th arch artery (Fig. 6D). However, in
mutant embryos at E12.5, the 4th arch artery connection
Fig. 6. 4th arch apoptosis at E12.5 Sections of normal (A, C–D) andWnt1cre/Tgfbr2 mutant (B, E–F) embryos were immunostained for smooth muscle actin (A–B,
C, E) or active caspase 3 (D, F). The sections of D and F are from the same embryos and are nearly adjacent to those shown in panels C and E, respectively. SMA
staining visualizes the location of the regressing left 4th arch artery between the ascending aorta and the dorsal aorta in the mutant embryo (E), the cells of which are
apoptotic (F).
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severed, and the smooth muscle actin-positive cells that had
previously surrounded this vessel were apoptotic (Figs. 6E–
F). There was no evidence of apoptosis in the left or right 4th
arch artery at E11.5, although cells surrounding the right 6th
arch artery in controls and in mutants were apoptotic at E11.5
as this vessel underwent normal regression (data not shown).
In three E12.5 mutants, we did not observe apoptotic cells
around the right 4th arch artery, suggesting that the variable
regression of this vessel in mutant embryos (causing retro-
esophageal right subclavian artery) is not associated with a
near–threshold level of apoptosis that is higher than in
controls. Apoptosis has previously been associated with the
left 4th arch artery in embryos lacking the TGFh2 ligand
(Molin et al., 2002), although IAA-B is a relatively rare
phenotype in such embryos (Sanford et al., 1997; Molin et al.,
2002).
A normal terminal fate of the cardiac neural crest cell lineage
in Wnt1cre/Tgfbr2 mutants
As described in our original description for wildtype embryos
(Jiang et al., 2000) and in control embryos described below, the
ultimate fate of the cardiac neural crest cell lineage is fairly
restricted. In the conotruncus, the extensive influx of neural crest
cells at earlier stages (E10.5; Fig. 4) is mostly overgrown, suchFig. 7. The ultimate fate of the neural crest cell lineage. (A–F) Near adjacent section
are shown, stained either for Xgal (upper row) or smooth muscle actin (lower row
adjacent to the left recurrent laryngeal nerve (n) from normal (G) and mutant (H) ethat there persisted a detectable although minor cellular
contribution to subvalvular structures and to the semilunar
valves (Fig. 7A). The extensive contribution of labeled cells
surrounding the aortic sac at E10.5 was also reduced to a thin
layer immediately adjacent to the endothelium of the ascending
aorta and pulmonary trunk (Fig. 7B); these cells were
immunoreactive as smooth muscle, although clearly, the bulk
of the smoothmuscle surrounding these vessels is derived from a
splanchnic mesodermal source. The ductus arteriosus and the
arch of the aorta, as well as the proximal carotid arteries (all are
derived from the aortic arch arteries), all retained an extensive
layer of smooth muscle that was mostly if not completely
derived from the neural crest cell lineage (Fig. 7C). The dorsal
aorta and the pulmonary arteries are never associated with neural
crest cells and were Xgal-negative at all stages.
In Wnt1cre/Tgfbr2 mutant embryos, a completely normal
terminal fate was observed for the neural crest cell lineage (Figs.
7D–F), albeit with the constraint that certain components of the
vascular system aremalformed (i.e., the outflow tract) or missing
(i.e., the arch of the aorta). Importantly, the presence of a normal
number of neural crest cells, and their differentiated fate as
smooth muscle, was apparent in mutant embryos at outflow
valve level (Fig. 7D), in the derivatives of the aortic sac (the
ascending aorta and the truncus arteriosus; Fig. 7E), and
surrounding the persisting derivatives of the pharyngeal arch
arteries (the ductus arteriosus, the more distal ascending aorta,s from a normal (A–C) and a Tgfbr2 mutant (D–F) littermate embryo at E14.5
). (G–H) Immunostaining for elastin in sections through the ductus arteriosus
mbryos at E17.5. Thy, thymic lobes.
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embryos, the neural crest-derived cells in vessel walls were
immunopositive for elastin, a marker of mature smooth muscle
(Figs. 7G, H). The only specific perturbation of neural crest cell
fate in mutant embryos was the inappropriate apoptosis of cells
surrounding the 4th arch artery, as described above. These
observations are consistent with a perspective in which the
neural crest cells that migrate into the outflow region of the heart
respond to local TGFh cues that direct certain specific
morphogenic processes (e.g., formation of the A/P septum,
maintenance of the 4th arch artery), but lacking these cues, the
cell lineage continues through development either according to a
preprogrammed or default fate, or according to other cues that
these cells receive from other sources.
Normal pharyngeal endoderm organ development in Wnt1cre/
Tgfbr2 mutants
The juxtaposition of neural crest cells with pharyngeal
endoderm is required for endodermal differentiation into
components of the thymus, thyroid, and parathyroid organs.
Significant reduction in cardiac neural crest cell number, such as
from neural crest ablation in chick embryos (Kirby and Waldo,
1995) or in mouse mutants lacking the Pax3 gene (Epstein et al.,
2000), results not only in persistent truncus arteriosus but also in
thymic, thyroid, and parathyroid defects. Human infants with
DiGeorge syndrome, a spectrum of malformations which
includes PTA and IAA-B as well as thymic and parathyroid
deficiencies, are believed to represent a similar failure in the
cardiac neural crest cell population. We therefore investigated
pharyngeal endodermal development in E17.5 Wnt1cre/Tgfbr2
mutants, although found that thymic, thyroid, and parathyroid
organogenesis seemed to be completed normally (Fig. 8). As
noted above, a normal number of neural crest cells were presentFig. 8. Normal pharyngeal organ development in Wnt1cre/Tgfbr2 mutant embryos.
pairs of images are at the same magnification. (A, B) Whole mount view of dissecte
the thyroid gland (Thr); arrows point to the parathyroids (because of section ang
hybridization analysis of parathyroid hormone expression (dark blue) in sections adin the pharyngeal arches at earlier stages (Fig. 4), and in
midgestation embryos were normally present around the
endodermal organ primordia (e.g., the thymus, Figs. 7C, F).
We conclude that TGFh signaling through the type II receptor is
not required for the early allocation of cardiac neural crest cell
number, nor for the interactions between endoderm and neural
crest that support endodermal organogenesis, but that TGFh
signal transduction by the cardiac neural crest cell lineage is
specifically involved in the initiation of A/P septation and
preservation of the 4th aortic arch artery.
Discussion
Roles of TGFb signaling and Tgfbr2 in smooth muscle
specification and differentiation
A primary fate of the postotic neural crest cell lineage is to
differentiate into the smooth muscle of the aortic arch arteries
and cardiac outflow tract (LeDouarin, 1982; Kirby and Waldo,
1995; Jiang et al., 2000). A small percentage of cranial
(preotic) neural crest cells also assume a smooth muscle
phenotype in the head. Our initial assumption, based on many
published studies (Shah et al., 1996; Abzhanov et al., 2003),
was that an inability by the neural crest cell lineage to respond
to TGFh would result in a failure in smooth muscle
differentiation. Surprisingly, we find that smooth muscle
specification and differentiation by these cells appears to occur
normally in the absence of Tgfbr2, and presumably therefore
does not require TGFh signaling.
One caveat to this interpretation is that we have only
manipulated the type II TGFh receptor, although in principle,
other means of responding to TGFh might still exist. For
example, the membrane-anchored factors betaglycan and
endoglin function as TGFh receptors, although these moleculesImages shown are of E18 control (A, C, E) and mutant (B, D, F) embryos; all
d thorax, showing the thymic lobes (Thy). (C, D) Histological sections through
le, only one parathyroid is present in the section shown in C). (E, F) In situ
jacent to those shown in C, D to illustrate normal parathyroid size.
B. Choudhary et al. / Developmental Biology 289 (2006) 420–429428lack a cytoplasmic domain that can transduce signals. Although
the specific function of these proteins in terms of TGFh
signaling is still unclear, one model holds that these may serve
as coreceptors that help present TGFh to the active type I-type
II receptor complex (Massague, 2000). Nonetheless, it cannot
be ruled out that these have signaling functions on their own, or
that these interact with other receptors in a manner that would
bypass a requirement for the type II TGFh receptor. Thus,
although mutation of the Tgfbr2 gene in the neural crest cell
lineage should abolish TGFh responsiveness, we cannot
formally disprove the existence of alternative pathways.
A number of studies have shown that isolated neural crest
cells explanted into cell culture will differentiate into smooth
muscle with high efficiency when treated with TGFh (Shah et
al., 1996; Abzhanov et al., 2003). Our fate mapping studies
indicate that trunk neural crest cells do not become smooth
muscle even in normal embryos. Possibly, TGFh is not
presented to the migrating trunk neural crest cell population
in a manner that would induce smooth muscle differentiation,
or possibly, TGFh induces a fate other than smooth muscle in
vivo. Arguing against this latter possibility is the absence of
obvious abdominal morphogenic defects in Wnt1cre/Tgfbr2
mutants. It is also possible that trunk neural crest cells are
simply non-responsive to TGFh in vivo, although these cells
are clearly responsive when cultured as primary cells in vitro.
The predominant fate of the cardiac neural crest cell
population is to become smooth muscle, although other fates
are also evident (e.g., neuronal cells of the vagus nerve,
mesenchymal components of the thymus and thyroid primor-
dia), and clearly a number of fates are also assumed by cranial
and trunk neural crest. We did not observe differences between
normal and Wnt1cre/Tgfbr2 embryos in smooth muscle
differentiation or in the commitment of neural crest cells to
any cell lineage, although we cannot rule out a subtle defect in
differentiation. Clearly, there are pronounced morphogenic
defects associated with neural crest-specific Tgfbr2 deficiency
in the cranial (Ito et al., 2003) and cardiac domains (PTA and
IAA-B; this study); however, these malformations appear to be
independent of smooth muscle differentiation. We therefore
suggest that the primary role of TGFh signaling to neural crest
cells in vivo is as a local morphogenic factor rather than as an
instructional cue for cell lineage specification or for smooth
muscle differentiation.
Roles of TGFb signaling and Tgfbr2 in cardiac outflow tract
and cranial morphogenesis
Although neural crest cell migration and smooth muscle
differentiation were normal in neural crest-specific Tgfbr2
mutants, we did observe two morphogenic defects in the
cardiovascular system—persistent truncus arteriosus and inter-
rupted aortic arch type B. IAA-B results from inappropriate
regression of the left 4th arch artery, which as described above
is associated with apoptosis of the neural crest-derived smooth
muscle that surrounds this vessel. PTA results from a failure to
properly construct the aorticopulmonary septum, which in
normal embryos is completely constituted by neural crest cells.PTA can result from an insufficient number of neural crest cells
reaching the aortic sac (Kirby and Waldo, 1995; Epstein et al.,
2000), although our fate mapping studies indicate that a normal
number of neural crest-derived cells are present throughout the
outflow tract in Wnt1cre/Tgfbr2 mutants, with a normal
proliferative rate, and there is no apoptosis within this cell
population. We do not yet understand the basis by which the
PTA phenotype arises, although preliminary evidence suggests
that neural crest cells in mutant embryos prematurely assume a
more highly differentiated non-mesenchymal morphology at
the distal end of the aortic sac (e.g., Figs. 4CC, FF). Possibly,
the persistence of a mesenchymal cellular phenotype is
necessary for the neural crest cells to properly organize into
the forming A/P septum, although at present, it is not
understood how this process occurs.
Our observations are consistent with a general model in
which local signals regulate the fate and function of neural
crest cells as they migrate to their terminal locations. TGFh is
one such signal that has two independent roles in cardiovas-
cular development: to direct the formation of the A/P septum in
the aortic sac, and to maintain the persistence of the 4th arch
artery. It is noteworthy that these two processes are mechanis-
tically distinct: IAA-B results from inappropriate apoptosis in
the 4th arch artery, whereas the PTA phenotype has no
association with apoptosis and may instead involve some
aspect of cell morphology. Similarly, cranial neural crest cells
respond to TGFh signals through the type II TGFh receptor in
a manner which is required for normal cranial morphogenesis,
via induction of proliferation (Ito et al., 2003). Why the
response of the neural crest cell population to TGFh signals
results in such different consequences is unclear. There may be
heterogeneity in the signal itself (e.g., different TGFh ligands
may have different effects on neural crest cells), or additional
cues in the local regions into which the neural crest cells
migrate may lead to such divergent responses.
While there are no cardiovascular defects in TGFh1- or
TGFh3-deficient embryos (Sanford et al., 1997), the defects
described here are partly seen in TGFh2-deficient embryos.
Thus, 4th arch artery defects were noted to occur with partial
penetrance in TGFb2 mutants (8% IAA-B, 20% hypoplastic
aortic arch (Sanford et al., 1997; Bartram et al., 2001; Molin et
al., 2002)), whereas PTA was a rare observation (one of 24
embryos studied). Both are completely penetrant phenotypes in
Wnt1cre/Tgfbr2 mutants, suggesting that several TGFh iso-
forms together regulate these morphogenic steps, obligatorily
through the type II TGFh receptor. A report of the con-
sequences of combined TGFb2/TGFb3 mutations (Dunker and
Krieglstein, 2002) did not discuss cardiovascular phenotypes
except to say that they coincide with those present in TGFb2
mutants alone; whether combined mutation results in an
increase in penetrance of these defects is currently unreported.
A very recent study by another group (Wurdak et al., 2005)
independently investigated the phenotype of Wnt1cre/Tgfbr2
mutant embryos, although reached very different conclusions
from ours. Both studies report PTA and IAA-B in all mutant
embryos, but whereas we see normal cardiac neural crest cell
number and normal smooth muscle differentiation, their study
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quent apoptosis. Furthermore, whereas we observe apparently
normal pharyngeal endodermal organ development, that study
reported thymic and parathyroid defects associated with
reduced neural crest cell number. A deficiency in pharyngeal
cardiac neural crest cell number is generally also associated
with myocardial dysfunction and midgestation lethality (Con-
way et al., 1997), although Wnt1cre/Tgfbr2 mutant embryos
were viable to full term in both studies. The same Wnt1cre
transgenic line was used in both, although the conditional
Tgfbr2 allele was different (although, both are predicted to be
unable to encode a protein following recombination). In
principle, the mice of the other study may have some additional
level of perturbation, whether of genetic or environmental
cause. Nonetheless, our results are clear and unambiguous that
Tgfbr2 elimination in the neural crest cell lineage causes PTA
without altering smooth muscle differentiation, and without
also causing pharyngeal organ (DiGeorge) phenotypes.
The phenotypes of several genes which have been tissue-
specifically deleted in the neural crest cell lineage have been
recently reported. Interestingly, several of these appear to
compromise smooth muscle differentiation in the cardiac
outflow tract, including those encoding the PDGF receptor a
(Tallquist and Soriano, 2003) and the putative BMP receptor
ALK2 (Kaartinen et al., 2004). However, global neural crest cell
differentiation to smooth muscle is not eliminated in these
mutants. This suggests a myriad of factors which influence
several aspects of neural crest cell differentiation and fate, with
some involved in localized smooth muscle differentiation, and
others such as TGFh involved in subsequent morphogenic
events.
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